Retinoic Acid Suppresses Human Papillomavirus Type 16 (HPV16)-Mediated Transformation of Human Keratinocytes and Inhibits the Expression of the HPV16 Oncogenes

  • Kim E. Creek
  • G. Ronald Jenkins
  • Mohammad A. Khan
  • Ayse Batova
  • John R. Hodam
  • William H. Tolleson
  • Lucia Pirisi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 375)

Abstract

It has been estimated that approximately 35% of cancer deaths occurring now may be related to diet, and that diet may constitute the greatest lifestyle contribution to cancer mortality.1 Of the numerous dietary constituents related to cancer risk, β-carotene and/or vitamin A have consistently been implicated as potential agents for the chemoprevention of cancer in humans.2–7 Vitamin A and its natural and synthetic derivatives (collectively known as retinoids) have been shown to inhibit both chemical8 and viral carcinogenesis.9,10 For example, retinoids inhibit skin carcinogenesis in the classic two-stage system11 and exert a marked inhibitory effect on the induction and development of virus-induced papilloma (Shope) of rabbit skin.9,10 In addition, numerous epidemiological studies have demonstrated an inverse correlation between dietary intake or blood levels of vitamin A and/or its precursors, the carotenoids, and cancer risk at several epithelial sites,12–17 including the cervix.18–21 Retinoids also may be effective in treating premalignant lesions such as cervical intraepithelial neoplasia (CIN).22–27 In fact, phase I and phase II clinical trials of all-trans-retinoic acid (RA) for CIN have shown that RA is capable of reversing cervical dysplasia in some patients, indicating that retinoids may be useful in the prevention and treatment of cervical malignancies.22–27

Keywords

Retinoic Acid Retinoic Acid Treatment Cervical Dysplasia Upstream Regulatory Region Human Foreskin Keratinocytes 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. Doll, R. Peto, The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today, J Natl Cancer Inst 66:1292 (1981).Google Scholar
  2. 2.
    J.S. Bertram, L.N. Kolonel, F.L. Meyskens, Rationale and strategies for chemoprevention of cancers in humans, Cancer Res 47:3012 (1987).PubMedGoogle Scholar
  3. 3.
    R. Peto, R. Doll, J.D. Buckley, M.B. Sporn, Can dietary beta-carotene materially reduce human cancer rates? Nature 290:201 (1981).CrossRefPubMedGoogle Scholar
  4. 4.
    R.C. Moon, L.M. Itri, Retinoids and cancer, in: The Retinoids, M.B. Sporn, A.B. Roberts, D.S. Goodman, eds., Vol. 2, p. 327, Academic Press, New York (1984).Google Scholar
  5. 5.
    G.L. Peck, Chemoprevention of cancer with retinoids, Gynecol Oncol 12:s331 (1981).CrossRefPubMedGoogle Scholar
  6. 6.
    D.L. Hill, C.L. Grubbs, Retinoids as chemopreventive and anticancer agents in intact animals (review), Anticancer Res 2:111 (1982).PubMedGoogle Scholar
  7. 7.
    S.M. Lippman, J.F. Kessler, F.L. Meyskens, Retinoids as preventive and therapeutic anticancer agents (part I), Cancer Treat Rep 71:391 (1987).PubMedGoogle Scholar
  8. 8.
    M.B. Sporn, N.M. Dunlop, D.L. Newton, Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids), Fed Proc 35:1332 (1976).PubMedGoogle Scholar
  9. 9.
    Y. Ito, Effect of an aromatic retinoic acid analog (RO 10-9359) on growth of virus-induced papilloma (Shope) and related neoplasia of rabbits, Eur J Cancer 17:35 (1981).PubMedGoogle Scholar
  10. 10.
    H. McMichael, Inhibition of growth of Shope rabbit papilloma by hypervitaminosis A, Cancer Res 25:947 (1965).PubMedGoogle Scholar
  11. 11.
    A.K. Verma, B.G. Shapas, H.M. Rice, R.K. Boutwell, Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion, Cancer Res 39:419 (1979).PubMedGoogle Scholar
  12. 12.
    E. Bjelke, Dietary vitamin A and human lung cancer, Int J Cancer 15:561 (1975).CrossRefPubMedGoogle Scholar
  13. 13.
    S. Graham, Results of case-control studies of diet and cancer in Buffalo, New York, Cancer Res 43:2409s (1983).PubMedGoogle Scholar
  14. 14.
    J.D. Kark, A.H. Smith, B.R. Switzer, C.G. Harnes, Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia, J Natl Cancer Inst 66:7 (1981).PubMedGoogle Scholar
  15. 15.
    C. Mettlin, S. Graham, M. Swanson, Vitamin A and lung cancer, J Natl Cancer Inst 62:1435 (1979).PubMedGoogle Scholar
  16. 16.
    R.B. Shekelle, M. Lepper, S. Liu, C. Maliza, WJ. Raynor, A.H. Rossof, O. Paul, A.M. Shyrock, J. Stamler, Dietary vitamin A and risk of cancer in the Western Electric study, Lancet ii: 1185 (1981).CrossRefGoogle Scholar
  17. 17.
    N. Wald, M. Idle, J. Boreham, A. Bailey, Low serum-vitamin-A and subsequent risk of cancer, Lancet ii:813 (1980).CrossRefGoogle Scholar
  18. 18.
    A. Bernstein, B. Harris, The relationship of dietary and serum vitamin A to the occurrence of cervical intraepithelial neoplasia in sexually active women, Am J Obstet Gynecol 148:309 (1984).PubMedGoogle Scholar
  19. 19.
    T. Hirayama, Diet and cancer, Nutr Cancer 1:67 (1979).CrossRefGoogle Scholar
  20. 20.
    J.R. Marshall, S. Graham, T. Byers, M. Swanson, J. Brasure, Diet and smoking in the epidemiology of cancer of the cervix, J Natl Cancer Inst 70:847 (1983).PubMedGoogle Scholar
  21. 21.
    S.L. Romney, P.R. Palan, C. Duttagupta, S. Wassertheil-Smoller, J. Wylie, G. Miller, N.S. Slagle, D. Lucido, Retinoids and the prevention of cervical dysplasias, Am J Obstet Gynecol 141:890 (1981).PubMedGoogle Scholar
  22. 22.
    V. Graham, E.A. Surwit, S. Weiner, F.L. Meyskens, Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap, West J Med 145:192 (1986).PubMedGoogle Scholar
  23. 23.
    F.L. Meyskens, V. Graham, M. Chvapil, R.T. Dorr, D.S. Alberts, E.A. Surwit, A phase I trial of β-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia, J Natl Cancer Inst 71:921 (1983).PubMedGoogle Scholar
  24. 24.
    F.L. Meyskens, E.S. Surwit, Clinical experience with topical tretinoin in the treatment of cervical dysplasia, J Am Acad Dermatol 15:826 (1986).CrossRefPubMedGoogle Scholar
  25. 25.
    Y.M. Peng, D.S. Alberts, V. Graham, E.A. Surwit, S. Weiner, F.L. Meyskens, Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen sponge-cervical cap delivery device in patients with cervical dysplasia, Invest New Drugs 4:245 (1986).CrossRefPubMedGoogle Scholar
  26. 26.
    E.A. Surwit, V. Graham, W. Droegemueller, D. Alberts, M. Chvapil, R.T. Dorr, J.R. Davis, F.L. Meyskens, Evaluation of topically applied trans-retinoic acid in the treatment of cervical intraepithelial lesions, Am J Obstet Gynecol 143:821 (1982).PubMedGoogle Scholar
  27. 27.
    S.A. Weiner, E.A. Surwit, V.E. Graham, F.L. Meyskens, A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy, Invest New Drugs 4:241 (1986).CrossRefPubMedGoogle Scholar
  28. 28.
    H. zur Hausen, Papillomaviruses in human cancers, Mol Carcinogenesis 1:147 (1988).CrossRefGoogle Scholar
  29. 29.
    H. zur Hausen, Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers, Cancer Res 49:4611 (1989).Google Scholar
  30. 30.
    L. Pirisi, S. Yasumoto, M. Feller, J. Doniger, J.A. DiPaolo, Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA, J Virol 61:1061 (1987).PubMedGoogle Scholar
  31. 31.
    L. Pirisi, K.E. Creek, J. Doniger, J.A. DiPaolo, Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA, Carcinogenesis 9:1573 (1988).CrossRefPubMedGoogle Scholar
  32. 32.
    M. Durst, R.T. Dzarlieva-Petrusevska, P. Boukamp, N.E. Fusenig, L. Gissmann, Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA, Oncogene 1:251 (1987).PubMedGoogle Scholar
  33. 33.
    C.D. Woodworth, J. Doniger, J.A. DiPaolo, Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma, J Virol 63:159 (1989).PubMedGoogle Scholar
  34. 34.
    P. Kaur, J.K. McDougall, Characterization of primary human keratinocytes transformed by human papillomavirus type 18, J Virol 62:1917 (1988).PubMedGoogle Scholar
  35. 35.
    CD. Woodworth, P.E. Bowden, J. Doniger, L. Pirisi, W. Barnes, W.D. Lancaster, J.A. DiPaolo, Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA, Cancer Res 48:4620 (1988).PubMedGoogle Scholar
  36. 36.
    R. Schlegel, W.C. Phelps, W.L. Zhang, M. Barbosa, Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma, EMBO J 5:3181 (1988).Google Scholar
  37. 37.
    C.C. Baker, W.C. Phelps, V. Lindgren, M.J. Braun, M.A. Gonda, P.M. Howley, Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines, J Virol 61:962 (1987).PubMedGoogle Scholar
  38. 38.
    E. Schwarz, U.K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, H. zur Hausen, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature 314:111 (1985).CrossRefPubMedGoogle Scholar
  39. 39.
    C. Yee, I. Krishnan-Hewlett, C.C Baker, R. Schlegel, P.M. Howley, Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines, Am J Pathol 119:361 (1985).PubMedGoogle Scholar
  40. 40.
    T. Crook, J.P. Morgenstern, L. Crawford, L. Banks, Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras, EMBO J 8:513 (1989).PubMedGoogle Scholar
  41. 41.
    P. Hawley-Nelson, K.H. Vousden, N.L. Hubbert, D.R. Lowy, J.T. Schiller, HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes, EMBO J 8:3905 (1989).PubMedGoogle Scholar
  42. 42.
    J.B. Hudson, M.A. Bedell, DJ. McCance, L.A. Laimins, Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18, J Virol 64:519 (1990).PubMedGoogle Scholar
  43. 43.
    M.S. Barbosa, R. Schlegel, The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes, Oncogene 4:1529 (1989).PubMedGoogle Scholar
  44. 44.
    CL. Halbert, G.W. Demers, D.A. Galloway, The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells, J Virol 65:473 (1991).PubMedGoogle Scholar
  45. 45.
    W.C Phelps, C.L. Yee, K. Munger, P.M. Howley, The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A, Cell 53:539 (1988).CrossRefPubMedGoogle Scholar
  46. 46.
    N. Dyson, P.M. Howley, K. Munger, E. Harlow, The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product, Science 243:934 (1989).CrossRefPubMedGoogle Scholar
  47. 47.
    K. Munger, B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, P.M. Howley, Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product, EMBO J 8:4099 (1989).PubMedGoogle Scholar
  48. 48.
    J.R. Gage, C. Meyers, F.O. Wettstein, The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties, J Virol 64:723 (1990).PubMedGoogle Scholar
  49. 49.
    B.A. Werness, AJ. Levine, P.M. Howley, Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science 248:76 (1990).CrossRefPubMedGoogle Scholar
  50. 50.
    K.E. Creek, C.S. Silverman-Jones, L.M. De Luca, Comparison of the uptake and metabolism of retinol delivered to primary mouse keratinocytes either free or bound to rat serum retinol-binding protein, J Invest Dermatol 92:283 (1989).CrossRefPubMedGoogle Scholar
  51. 51.
    S. Yasumoto, J. Doniger, J.A. DiPaolo, Differential early viral gene expression in two stages of human papillomavirus type 16 DNA-induced malignant transformation, Mol Cell Biol 7:2165 (1987).PubMedGoogle Scholar
  52. 52.
    U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227:680 (1970).CrossRefPubMedGoogle Scholar
  53. 53.
    S.D. Dunn, Effects of the modification of transfer buffer composition and renaturation of proteins in gels on the recognition of proteins on western blots by monoclonal antibodies, Anal Biochem 157:144 (1986).CrossRefPubMedGoogle Scholar
  54. 54.
    L. Pirisi, A. Batova, G.R. Jenkins, J.R. Hodam, K.E. Creek, Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids, Cancer Res 52:187 (1992).PubMedGoogle Scholar
  55. 55.
    M. Petkovich, N.J. Brand, A. Krust, P. Chambon, A human retinoic acid receptor which belongs to the family of nuclear receptors, Nature 330:444 (1987).CrossRefPubMedGoogle Scholar
  56. 56.
    V. Giguere, E.S. Ong, P. Segui, R.M. Evans, Identification of a receptor for the morphogen retinoic acid, Nature 330:624 (1987).CrossRefPubMedGoogle Scholar
  57. 57.
    R.M. Evans, The steroid and thyroid hormone receptor superfamily, Science 240:889 (1988).CrossRefPubMedGoogle Scholar
  58. 58.
    L.J. Gudas, Retinoids, retinoid-responsive genes, cell differentiation, and cancer, Cell Growth Differentiation 3:655 (1992).PubMedGoogle Scholar
  59. 59.
    L.M. De Luca, Retinoids and their receptors in differentiation, embryogenesis, and neoplasia, FASEB J 5:2924 (1991).PubMedGoogle Scholar
  60. 60.
    N. Brand, M. Petkovich, A. Krust, P. Chambon, H. de The, A. Marchio, P. Tiollais, A. Dejean, Identification of a second human retinoic acid receptor, Nature 332:850 (1988).CrossRefPubMedGoogle Scholar
  61. 61.
    D. Benbrook, E. Lernhardt, M. Pfahl, A new retinoic acid receptor identified from a hepatocellular carcinoma, Nature 333:669 (1988).CrossRefPubMedGoogle Scholar
  62. 62.
    A. Krust, P. Kastner, M. Petkovich, A. Zelent, P. Chambon, A third human retinoic acid receptor, hRAR-gamma, Proc Natl Acad Sci USA 86:5310 (1989).CrossRefPubMedGoogle Scholar
  63. 63.
    A. Zelent, A. Krust, M. Petkovich, P. Kastner, P. Chambon, Cloning of murine α and β retinoic acid receptors and a novel receptor gamma predominantly expressed in skin, Nature 339:714 (1989).CrossRefPubMedGoogle Scholar
  64. 64.
    K. Umesono, V. Giguere, C.K. Glass, M.G. Rosenfeld, R.M. Evans, Retinoic acid and thyroid hormone induce gene expression through a common responsive element, Nature 336:262 (1988).CrossRefPubMedGoogle Scholar
  65. 65.
    B. Gloss, H.U. Bernhard, K. Seedorf, G.A. Klock, A DNA segment of the upstream regulatory region of the human papillomavirus-16 exhibits E2 protein-independent enhancer activity in a glucocorticoid hormone-regulated and cell type-specific fashion, EMBO J 6:3735 (1987).PubMedGoogle Scholar
  66. 66.
    T. Chong, W.K. Chan, H.U. Bernard, Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: A model for the composition of genital papillomavirus enhancers, Nucleic Acids Res 18:465 (1990).CrossRefPubMedGoogle Scholar
  67. 67.
    R.C. Nicholson, S. Mader, S. Nagpal, M. Leid, C. Rochette-Egly, P. Chambon, Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site, EMBO J 9:4443 (1990).PubMedGoogle Scholar
  68. 68.
    D. Bartsch, B. Boye, C. Baust, H. zur Hausen, E. Schwarz, Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrids, EMBO J 11:2283 (1992).PubMedGoogle Scholar
  69. 69.
    A. Batova, D. Danielpour, L. Pirisi, K.E. Creek, Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes, Cell Growth Differentiation 3:763 (1992).PubMedGoogle Scholar
  70. 70.
    A.B. Glick, K.C. Flanders, D. Danielpour, S.H. Yuspa, M.B. Sporn, Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis, Cell Regulation 1:87 (1989).PubMedGoogle Scholar
  71. 71.
    G.D. Shiply, M.R. Pittelkow, J.J. Wille, R.E. Scott, H.L. Moses, Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium, Cancer Res 46:2068 (1986).Google Scholar
  72. 72.
    R.J. Coffey, N.J. Sipes, C.C. Bascom, R. Graves-Deal, C.Y. Pennington, B.E. Weissman, H.L. Moses, Growth modulation of mouse keratinocytes by transforming growth factors, Cancer Res 48:1596 (1988).PubMedGoogle Scholar
  73. 73.
    M. Reiss, A.C. Sartorelli, Regulation of growth and differentiation of human keratinocytes by type β transforming growth factor and epidermal growth factor, Cancer Res 47:6705 (1987).PubMedGoogle Scholar
  74. 74.
    P.A. Dennis, D.B. Rifkin, Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor, Proc Natl Acad Sci USA 88:580 (1991).CrossRefPubMedGoogle Scholar
  75. 75.
    C.D. Woodworth, V. Notario, J.A. DiPaolo, Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells, J Virol 64:4767 (1990).PubMedGoogle Scholar
  76. 76.
    J.A. Pietenpol, R.W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R.M. Lyons, M.R. Pittelkow, K. Munger, P.M. Howley, H.L. Moses, TGF-α1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains, Cell 61:777 (1990).CrossRefPubMedGoogle Scholar
  77. 77.
    C. Agarwal, E.A. Rorke, J.C. Irwin, R.L. Eckert, Immortalization by human papillomavirus type 16 alters retinoid regulation of human ectocervical epithelial cell differentiation, Cancer Res 51:3982 (1991).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Kim E. Creek
    • 1
  • G. Ronald Jenkins
    • 1
  • Mohammad A. Khan
    • 2
  • Ayse Batova
    • 1
  • John R. Hodam
    • 1
  • William H. Tolleson
    • 2
  • Lucia Pirisi
    • 2
  1. 1.Department of Chemistry and BiochemistryUniversity of South CarolinaColumbiaUSA
  2. 2.Department of PathologyUniversity of South Carolina School of MedicineColumbiaUSA

Personalised recommendations